Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment

Biochemical and Biophysical Research Communications

Volumn 441, Issue 1, 2013, Pages 144-150

  Sustarsic, Elahu G ^a   Junnila, Riia K ^a   Kopchick, John J ^a,b  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Cancer; Growth hormone; Growth hormone receptor; Melanoma; Prolactin receptor

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROLACTIN; PROLACTIN RECEPTOR; RECOMBINANT GROWTH HORMONE; STAT5 PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CLASSIFICATION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA CELL; METASTATIC MELANOMA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR CELL LINE; BIOPSY; CANCER GRADING; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; MALE; MELANOMA; METABOLISM; METASTASIS; PATHOLOGY;

BIOPSY; CELL LINE, TUMOR; CELL PROLIFERATION; DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH HORMONE; HUMANS; MALE; MELANOMA; NEOPLASM GRADING; NEOPLASM METASTASIS; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84887431034     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.023     Document Type: Article

References (37)

1. S. Harvey Extrapituitary growth hormone Endocrine 38 2010 335 359
2. S. Bernichtein, P. Touraine, and V. Goffin New concepts in prolactin biology J. Endocrinol. 206 2010 1 11
3. A.A. Hayashi, and C.G. Proud The rapid activation of protein synthesis by growth hormone requires signaling through mTOR Am. J. Physiol. Endocrinol. Metab. 292 2007 E1647 E1655
4. Y. Chhabra, M.J. Waters, and A.J. Brooks Role of the growth hormone-IGF-1 axis in cancer Expert Rev. Endocrinol. Metab. 6 2011 71 84
5. P.E. Clayton, I. Banerjee, P.G. Murray, and A.G. Renehan Growth hormone, the insulin-like growth factor axis, insulin and cancer risk Nat. Rev. Endocrinol. 7 2011 11 24
6. A. Martino, G. Cammarota, R. Cianci, A. Bianchi, E. Sacco, L. Tilaro, E. Marzetti, M. Certo, G. Pirozzi, and P. Fedeli High prevalence of hyperplastic colonic polyps in acromegalic subjects Dig. Dis. Sci. 49 2004 662 666
7. A.G. Renehan, and B.M. Brennan Acromegaly, growth hormone and cancer risk Best Pract. Res. Clin. Endocrinol. Metab. 22 2008 639 657
8. S. Dagdelen, N. Cinar, T. Erbas, Increased thyroid cáncer risk in acromegaly, Pituitary (July 09, 2013) Epub.
9. J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, M. Wei, F. Madia, C.W. Cheng, D. Hwang, A. Martin-Montalvo, J. Saavedra, and S. Ingles Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans Sci. Transl. Med. 3 2011 70ra13
10. Y. Ikeno, G.B. Hubbard, S. Lee, L.A. Cortez, C.M. Lew, C.R. Webb, D.E. Berryman, E.O. List, J.J. Kopchick, and A. Bartke Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice J. Gerontol. A Biol. Sci. Med. Sci. 64 2009 522 529
11. M. Pollak, M.J. Blouin, J.C. Zhang, and J.J. Kopchick Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist Br. J. Cancer 85 2001 428 430
12. Z. Wang, R.M. Luque, R.D. Kineman, V.H. Ray, K.T. Christov, D.D. Lantvit, T. Shirai, S. Hedayat, T.G. Unterman, and M.C. Bosland Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat Endocrinology 149 2008 1366 1376
13. S.M. Swanson, and T.G. Unterman The growth hormone-deficient spontaneous dwarf rat is resistant to chemically induced mammary carcinogenesis Carcinogenesis 23 2002 977 982
14. Z.S. Wu, K. Yang, Y. Wan, P.X. Qian, J.K. Perry, J. Chiesa, H.C. Mertani, T. Zhu, and P.E. Lobie Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma J. Clin. Endocrinol. Metab. 96 2011 E1619 E1629
15. C. Decouvelaere, J.P. Peyrat, J. Bonneterre, J. Djiane, and H. Jammes Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer Cell Growth Differ. 6 1995 477 483
16. D.T. Lincoln, F. Sinowatz, S. Kolle, H. Takahashi, P. Parsons, and M. Waters Up-regulation of growth hormone receptor immunoreactivity in human melanoma Anticancer Res. 19 1999 1919 1931
17. H.C. Mertani, T. Garcia-Caballero, A. Lambert, F. Gerard, C. Palayer, J.M. Boutin, B.K. Vonderhaar, M.J. Waters, P.E. Lobie, and G. Morel Cellular expression of growth hormone and prolactin receptors in human breast disorders Int. J. Cancer 79 1998 202 211
18. M. Gebre-Medhin, L.G. Kindblom, H. Wennbo, J. Törnell, and J.M. Meis-Kindblom Growth hormone receptor is expressed in human breast cancer Am. J. Pathol. 158 2001 1217 1222
19. E. Weiss-Messer, O. Merom, A. Adi, R. Karry, M. Bidosee, R. Ber, A. Kaploun, A. Stein, and R.J. Barkey Growth hormone (GH) receptors in prostate cancer: Gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells Mol. Cell. Endocrinol. 220 2004 109 123
20. J.N. Weinstein Spotlight on molecular profiling: "integromic" analysis of the NCI-60 cancer cell lines Mol. Cancer Ther. 5 2006 2601 2605
21. J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A.A. Margolin, S. Kim, C.J. Wilson, J. Lehár, G.V. Kryukov, and D. Sonkin The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity Nature 483 7391 2012 603 607
22. A.K. Patra, R. Mukhopadhyay, R. Mukhija, A. Krishnan, L.C. Garg, and A.K. Panda Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli Protein Expression Purif. 18 2000 182 192
23. D. Tan, K.E. Chen, T. Khoo, and A.M. Walker Prolactin increases survival and migration of ovarian cancer cells: Importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists Cancer Lett. 310 2011 101 108
24. G. Swaminathan, B. Varghese, and S.Y. Fuchs Regulation of prolactin receptor levels and activity in breast cancer J. Mammary Gland Biol. Neoplasia 13 2008 81 91
25. E.J. Yoo, I. Cajiao, J.S. Kim, A.P. Kimura, A. Zhang, N.E. Cooke, and S.A. Liebhaber Tissue-specific chromatin modifications at a multigene locus generate asymmetric transcriptional interactions Mol. Cell. Biol. 26 2006 5569 5579
26. D.T. Lincoln, F. Sinowatz, S. Kolle, H. Takahashi, P. Parsons, and M. Waters Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells Histochem. Cell Biol. 109 1998 141 159
27. M. Ginarte, T. Garcia-Caballero, V. Fernandez-Redondo, A. Beiras, and J. Toribio Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities J. Cutan. Pathol. 27 2000 276 282
28. A. Stanimirovic, H. Cupic, B. Bosnjak, D. Tomas, B. Kruslin, and M. Belicza TP53, bcl-2 and growth hormone receptor expression in cutaneous squamous cell carcinoma Acta Dermatovenerol. Croat. 13 2005 201 205
29. P.E. Lobie, W. Breipohl, D.T. Lincoln, J. Garcia-Aragon, and M.J. Waters Localization of the growth hormone receptor/binding protein in skin J. Endocrinol. 126 1990 467 471
30. A. Tavakkol, J.T. Elder, C.E. Griffiths, K.D. Cooper, H. Talwar, G.J. Fisher, K.M. Keane, S.K. Foltin, and J.J. Voorhees Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin J. Invest. Dermatol. 99 1992 343 349
31. J.C. Hassel, D. Winnemoller, M. Schartl, and C. Wellbrock STAT5 contributes to antiapoptosis in melanoma Melanoma Res. 18 2008 378 385
32. M. Schartl, B. Wilde, J.A. Laisney, Y. Taniguchi, S. Takeda, and S. Meierjohann A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies J. Invest. Dermatol. 130 2010 249 258
33. O.N. Ikediobi, H. Davies, G. Bignell, S. Edkins, C. Stevens, S. O'Meara, T. Santarius, T. Avis, S. Barthorpe, and L. Brackenbury Mutation analysis of 24 known cancer genes in the NCI-60 cell line set Mol. Cancer Ther. 5 2006 2606 2612
34. X. Xie, E.P. White, and J.M. Mehnert Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma PLoS One 8 2013 e55096
35. A. Gomez-Pinillos, and A.C. Ferrari MTOR signaling pathway and mTOR inhibitors in cancer therapy Hematol. Oncol. Clin. North Am. 26 2012 483 505
36. G. Caldarola, C. Battista, and R. Pellicano Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy Clin. Ther. 32 2010 57 59
37. M.Z. Handler, A.L. Ross, M.I. Shiman, G.W. Elgart, and J.M. Grichnik Potential role of human growth hormone in melanoma growth promotion Arch. Dermatol. 148 2012 1179 1182